Another PBM Favors Sandoz And Boehringer On Adalimumab

Humira Rivals Hyrimoz And Cyltezo Get Preferred Status From Express Scripts

 
• By Dave Wallace
  
Express Scripts Headquarters
Express Scripts has awarded preferred status to Sandoz and Boehringer’s biosimilars • Source: Shutterstock

More from Biosimilars

More from Products